ArticleOncology letters2015

Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab.

Aniello DE Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.